2025 Pulmonary and Critical Care Medicine Fellows Course (INVITE ONLY)-VAPS download pre adjustments

VAPS download pre adjustments

Pdf Summary

This compliance and therapy report covers the period from October 20, 2023, to November 7, 2023, tracking the use and performance of the AirCurve 10 ST-A device operating in iVAPS mode with set parameters: Target Alveolar Ventilation at 3.8 L/min, EPAP at 14 cmH2O, and pressure support ranging from 4 to 6 cmH2O.<br /><br />Usage compliance was excellent, with the device used every day (19/19 days, 100%), and nearly all days (95%) had usage of 4 or more hours. The average daily usage was 8 hours and 37 minutes, with a median of 8 hours and 59 minutes. Total hours used since last reset reached 6,898.<br /><br />Leak measurements showed a median of 21.0 L/min, with the 95th percentile at 51.6 L/min and a maximum of 65.3 L/min, slightly above the set threshold of 24 L/min but acceptable within expected ranges. The apnea-hypopnea index (AHI) was very low at 0.5 events per hour, indicating effective therapy, with no central apneas detected (AI=0.0) and hypopneas at 0.5 events/hour.<br /><br />Additional respiratory parameters showed an average tidal volume median of 203 ml, respiratory rate median of 24 breaths per minute against a target of 15 bpm, and minute ventilation median at 5.2 L/min. Alveolar ventilation median was 3.2 L/min. Spontaneous breaths were triggered 91% of the time and cycled 23%. The I:E (inspiratory to expiratory) ratio median was 1:1.74.<br /><br />Overall, the report reflects very good compliance and effective therapy delivery, with consistent usage and physiological parameters within therapeutic goals.

Keywords

AirCurve 10 ST-A

iVAPS mode

Target Alveolar Ventilation

EPAP 14 cmH2O

Pressure Support 4-6 cmH2O

Usage Compliance

Leak Measurements

Apnea-Hypopnea Index

Respiratory Rate

Therapy Effectiveness